Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: A Fmri Study on the Effects of a Conjugate Vaccine and Placebo on CNS Activation and Behavior Following a Nicotine Challenge [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial at Maastricht University Medical Center evaluated a nicotine-conjugate vaccine versus placebo and its e…
-
FDA approval · 2013-02-22FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor (nicotine polacrilex gum) from Rugby Laboratories…
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of NicVAX co-administered with varenicline for smoking cessation; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers [Phase 1]
A completed Phase 1 trial evaluating pharmacotherapy to reduce cue-responsiveness in individuals with nicotine or tobacco dependence. The sp…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain [Phase 1, Phase 2]
A combined low-dose naltrexone and bupropion trial for smoking cessation with reduced weight gain was completed (Phase 1/2).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Message Framing for Telephone Quitline Callers [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating message framing for telephone quitline callers completed; results posted in 2013.
-
FDA approval · 2013-01-28FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
FDA approved Walgreens' supplemental application for NICOTINE POLACRILEX MINT, a nicotine replacement therapy product containing nicotine po…
-
FDA approval · 2013-01-28FDA Approved: RUGBY NICOTINE POLACRILEX GUM, COATED MINT FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Coated Mint Flavor, from Rugby Laboratories. The approval expands…
-
FDA approval · 2013-01-28FDA Approved: NICOTINE — Supplemental Application (Lucy Goods, Inc.)
The FDA has approved a supplemental application for nicotine polacrilex (nicotine gum) from Lucy Goods, Inc.
-
FDA approval · 2013-01-28FDA Approved: NICOTINE POLACRILEX — Supplemental Application (Walgreens)
FDA approved Walgreens' supplemental application for NICOTINE POLACRILEX, granting an additional approval for this nicotine replacement ther…
-
FDA approval · 2013-01-28FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)
FDA approved a supplemental application for NICOTINE (nicotine polacrilex) submitted by P & L Development, LLC under ANDA079044. This indica…
-
FDA approval · 2013-01-28FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor, a nicotine replacement therapy intended to aid s…
-
FDA approval · 2013-01-28FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)
The FDA approved a supplemental application for nicotine polacrilex (nicotine) by P & L Development, LLC under ANDA079038, supporting its us…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: A Controlled Laboratory Study of the Effects on Cue-Induced Craving in Dependent Smokers [Phase 2]
Phase 2 clinical trial evaluating cue-induced craving in nicotine-dependent smokers; the study has completed and results were posted in 2013…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Multiple Cigarette Induced Changes in Hormone Function, Mood States and Behavior [NA]
Clinical trial status update indicating that the Nicotine Dependence study on cigarette-induced changes in hormone function, mood states, an…
-
CLINICAL_TRIALS research · 2013-01-15Clinical Trial Update: Smoked Nicotine Induced Changes in Hormone Function, Mood States and Behaviors [NA]
The clinical trial investigating smoked nicotine's effects on hormone function, mood states, and behaviors in nicotine dependence is current…
-
CLINICAL_TRIALS research · 2013-01-15Clinical Trial Update: Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects [NA]
Clinical trial NCT01636336 sponsored by McLean Hospital is investigating whether progesterone modulates smoked nicotine–induced hormonal cha…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Study of Nicotine Patch in Pregnancy (SNIPP) [Phase 3]
A Phase 3 trial evaluating the nicotine patch for smoking cessation in pregnant women has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes [NA]
This clinical trials entry reports a completed study evaluating the pharmacokinetics of nicotine and other toxic substances associated with …
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: rTMS Effects on Smoking Cessation and Cognition in Schizophrenia [NA]
A completed clinical trial evaluated repetitive transcranial magnetic stimulation (rTMS) for smoking cessation and cognitive outcomes in ind…
-
FDA approval · 2012-11-29FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for Equate Nicotine gum (nicotine polacrilex) from Wal-Mart Stores Inc., confirming market autho…
-
FDA approval · 2012-11-29FDA Approved: DG HEALTH NICOTINE — Supplemental Application (Dolgencorp Inc)
FDA approved a supplemental application for DG HEALTH NICOTINE (nicotine polacrilex) from Dolgencorp Inc.
-
FDA approval · 2012-11-29FDA Approved: NICOTINE — Supplemental Application (H E B)
FDA approved a supplemental application for NICOTINE products (NICOTINE and NICOTINE POLACRILEX) from H E B under an ANDA.
-
FDA approval · 2012-11-29FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for Equate Nicotine (nicotine polacrilex gum) submitted by Wal-Mart Stores Inc under an existing…
-
FDA approval · 2012-11-29FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for EQUATE NICOTINE (nicotine polacrilex) from Wal-Mart Stores Inc.